Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona

Affiliations

• ¹ Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy.
• ² Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy; Centro Ricerche Cliniche di Verona (CRC), Verona, Italy.
• ³ Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy; Department of Oncology, Surgery and Gastroenterology, University of Padova, Padua, Italy.
• ⁴ Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.
• ⁵ Veneto Tumor Registry, Azienda Zero, Padua, Italy.
• ⁶ Section of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
• ⁷ Department of Diagnostic and Public Health, Microbiology Section, University of Verona, Verona, Italy.
• ⁸ Section of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
• ⁹ Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy. Electronic address: [email protected].